Technology is at the heart of our team's passion.
T2Direct Diagnostics utilize proprietary T2 Magnetic Resonance (T2MR®) technology to enable faster and more accurate identification for pathogens that cause sepsis. At the system’s core is the innovative FDA-cleared T2Dx® Instrument, which enables running diagnostic tests direct from whole blood. The FDA-cleared T2Dx Instrument, T2Bacteria® Panel, and T2Candida® Panel are now commercially available.
And this is only the beginning. We are developing products for rapid bacteria detection and hemostasis measurements, which could impact over 11 million patients. We’ve also entered into a partnership with Canon U.S. Life Sciences to improve the detecton of Lyme disease-causing pathogens – a debilitating disease where 3.4 million tests are performed on patients annually.
Learn more about our culture of innovation and collaboration.